Skip to content

BrainInsight

by Hyperfine, Inc. 2 variants

510(k) K223268

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK223268 Date16 Dec 2022ClearedStatusActive

Official records

From the FDA record

Received by the FDA
24 Oct 2022
FDA decision
16 Dec 2022 (Substantially Equivalent)
FDA review time
53 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K223268 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QIH
Device class
Class II
Regulation
21 CFR Part 892.2050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

BrainInsight is an AI-powered software device designed for automated post-processing of magnetic resonance imaging (MRI) brain scans. It leverages machine learning to analyze ultra-low-field MRI images, enabling the labeling, segmentation, and measurement of brain structures. The system provides clinicians with annotated images, color overlays, and structured reports to assist in evaluating brain anatomy and pathology. This tool is classified under the FDA’s Radiology category and is intended for use in acute and critical care settings.

BrainInsight is supplied as a cloud-based software solution and integrates with FDA-cleared Picture Archiving and Communication Systems (PACS). It is intended for single-use per imaging session, though the underlying software platform may support multiple deployments. The device operates in environments such as emergency departments and intensive care units, where rapid diagnostic insights are critical. Authorized under FDA 510(k) clearance (K223268), it adheres to regulatory standards for AI-driven medical imaging software.

Similar devices

Other devices filed under FDA product code QIH (Automated Radiological Image Processing Software).

Other devices from Hyperfine, Inc.

See all devices from Hyperfine, Inc. →